Items tagged with Research and development
Advocates encourage prioritization of drug-resistant TB research (post with simple image)
TB advocates encourage the Global Antimicrobial Resistance Innovation Fund to prioritize research and development for drug-resistant TB.
Advocates encourage Danaher to continue investments in Cepheid’s TB products (post with simple image)
TB advocates encourage Danaher, a holdings company that recently acquired Cepheid, to prioritize the continued development of critical Cepheid products for TB.
Public health groups welcome Johns Hopkins University and Medicines Patent Pool agreement for development of promising new TB drug (post with simple image)
While deal marks a critical step in the fight against TB, health groups warn that the deal lacks safeguards that would ensure worldwide affordability.
Advocates call on Sequella to provide open access to sutezolid data (post with simple image)
TB advocates appeal to Sequella to act in the interest of public health and provide open access to all existing sutezolid data.
G-FINDER report 2016 (post with simple image)
The report analyses trends and patterns in 2015 for 35 neglected diseases - including TB - across 142 product areas including drugs, vaccines, diagnostics, microbicides and vector control products.
Sign a petition: Include TB in the WHO priority pathogens list for R&D of new antibiotics (post with simple image)
Global TB community calls for the World Health Organization (WHO) to include Mycobacterium tuberculosis in the list of bacteria for which new antibiotics are urgently needed.
Join the #TBontheList campaign (post with simple image)
Global TB community demands inclusion of Mycobacterium tuberculosis in the WHO's Global priority list of antibiotic-resistant bacteria to guide research, discovery and development of new antibiotics.
TB community demands WHO to include #TBontheList! (post with simple image)
The Stop TB Partnership delivered the letter to WHO requesting inclusion of Mycobacterium tuberculosis in the WHO's Global priority list of antibiotic-resistant bacteria to guide research, discovery and development of new antibiotics. Thank you for your support!
No time to lose: G20 leadership in TB research needed to end TB (post with simple image)
Treatment Action Group, Health GAP, AIDS-Free World, and Treatment Action Campaign urge G20 leaders to fund research to end TB.
MSF urges pharmaceutical corporations to release clinical data to help develop urgently needed new TB regimens (post with simple image)
Médecins Sans Frontières (MSF) urges Sequella and Pfizer to provide open access to all existing clinical data for sutezolid to help accelerate the research and development of urgently needed new, lifesaving TB treatment regimes.
Page 12 of 13 · Total posts: 0←First 11 12 13 Last→